Commercial Functions in Biotechnology and Pharmaceutical Companies

Harvard Extension School

BIOT E-209

Section 1

CRN 17450

View Course Details
This course fills a critical gap in biotechnology (biotech) education by explaining how commercial decision-making shapes the success of biotech and pharmaceutical companies. Students gain a practical understanding of how marketing, market analytics, and sales decisions are made across the product lifecycle, from late-stage pipeline through launch and ongoing competitive readiness, and why these decisions matter for fundraising, business development, and portfolio strategy as well as for on-market execution. Designed for scientists, clinicians, sales, medical affairs, and early commercial professionals, the course builds commercial fluency through applied frameworks, real-world cases, and role-based perspectives. Students learn how commercial assumptions influence valuation, partnering, and investment decisions, and how companies decide where to invest, what to prioritize, and how to compete once products reach the market. By the end of the course, students are able to participate credibly in commercial, cross-functional, and investment-related discussions and to understand how scientific innovation translates into both patient impact and enterprise value.

Instructor Info

Alex Pederson, JD

Partner, Alloy Bio Consulting


Meeting Info

T 8:10pm - 10:10pm (8/31 - 12/19)

Participation Option: Online Synchronous

Deadlines

Last day to register:

Notes

This course meets via web conference. Students must attend and participate at the scheduled meeting time. See minimum technology requirements.

All Sections of this Course

CRN Section # Participation Option(s) Instructor Section Status Meets Term Dates
17450 1 Online Synchronous Alex Pederson Open T 8:10pm - 10:10pm
Aug 31 to Dec 19